Marie-Christine Birling Selected Research

Marie-Christine Birling Research Topics

3	Pain (Aches) 01/2022 - 05/2020
3	Intellectual Disability (Idiocy) 01/2019 - 12/2015
2	Epilepsy (Aura) 01/2019 - 01/2018
1	Infections 10/2019
1	Trisomy (Trisomies) 10/2019
1	Malformations of Cortical Development 01/2019
1	Insulin Resistance 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Fragile X Tremor Ataxia Syndrome 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Nevus (Nevi) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Peeling Skin Syndrome 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2016
1	Frontotemporal Dementia (Semantic Dementia) 01/2016
1	Parkinsonian Disorders (Parkinsonism) 12/2015
1	Glucose Intolerance 12/2014
1	Proteinuria 10/2014
1	Neuroblastoma 03/2002

2	Voltage-Gated Sodium ChannelsIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2014
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2016 - 03/2002
1	AcetoneIBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 05/2020
1	N- (tris((beta- galactopyranosyloxy)methyl)methyl)- N(alpha)- (4- (5- cholesten- 3 beta-yloxy)succinyl)glycinamideIBA 10/2019
1	ElementsIBA 10/2019
1	TubulinIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	polyalanineIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	5' Untranslated Regions (5' UTR)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Thymic Stromal LymphopoietinIBA 01/2016
1	Interleukin-1 (Interleukin 1)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Interleukin-23 (Interleukin 23)IBA 01/2016
1	Adenosine Triphosphatases (ATPase)IBA 12/2015
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 12/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2014
1	GlycogenIBA 10/2014